Clinical trials
Leprosy clinical trials
Below are recruiting leprosy clinical trials, each written for real people, not researchers. We’re tracking 8 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07515989Recruiting
Testing a nerve biopsy method to diagnose leprosy
This study tests a new way to diagnose leprosy by taking a tiny sample from a nerve under the skin using ultrasound guidance. The goal is to see if this method can accurately detect leprosy and help doctors know when treatment is working.
Brasília, Federal DistrictAges 14 years+ - NCT05243654RecruitingPhase 2
Metformin add-on for newly diagnosed leprosy treatment
This Phase 2 trial tests whether adding metformin to standard leprosy treatment (multidrug therapy, or MDT) helps people with multibacillary leprosy recover better and remain tolerable over 48 weeks. Participants also get monitored closely for side effects and safety issues.
Tangerang, BantenAges 18–65 - NCT05597280RecruitingPhase 3
Medicine given after exposure to prevent leprosy
This Phase 3 study tests whether taking preventive antibiotics after possible contact can stop leprosy from developing. If it works, it could protect people in affected communities from getting leprosy (and possibly related infections).
MoroniAges 2 years+ - NCT06222372Recruiting
New approaches for leprosy diagnosis and treatment
This study looks at new ways to diagnose and treat leprosy. It includes patients with a more serious form of leprosy and the people who live closely with them, to help stop the spread of the disease.
NilphamariAges 5 years+ - NCT06683690Recruiting
Gene study in leprosy patients on treatment
This study looks at certain genes (TGF beta 1) in people with leprosy who are already taking multidrug therapy. It aims to understand how these genes might affect the disease, which could lead to better treatments in the future.
AswānAges 18–50 - NCT06819449Recruiting
Gene Study for Leprosy Prognosis
This study looks at whether a specific gene (Rab 32) affects how leprosy progresses. It may help doctors better predict outcomes for people with leprosy.
QinaAges 5–60 - NCT07172659RecruitingPhase 2
Study of Dovramilast for Leprosy Type 2 Reaction
This study tests a new medicine called dovramilast for people with leprosy type 2 reaction, a painful inflammatory condition that can cause skin bumps and nerve problems. It compares the study drug to standard care to see if it is safe and effective.
Seattle, WashingtonAges 18 years+ - NCT06599411Recruiting
Skin biomarkers for inflammatory disease treatment
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
ParisAges 18 years+
Hear when a new Leprosy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for leprosy?
- Yes. Clin2 currently lists 8 recruiting leprosy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a leprosy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a leprosy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.